These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21141266)

  • 1. [Population analysis by area of health of changes in consumption, price and expenditure of cardiovascular drugs in eight autonomous communities, Spain, 2005].
    Sanfélix-Gimeno G; Peiró S; Librero J; Ausejo-Segura M; Suárez-Alemán C; Molina-López T; Concepción CM; Castaño-Riera E;
    Rev Esp Salud Publica; 2010; 84(4):389-407. PubMed ID: 21141266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Variations in antihypertensive drug utilization among primary care areas in the autonomous region of Valencia (Spain)].
    Sanfélix-Gimeno G; Peiró S; Librero J;
    Gac Sanit; 2010; 24(5):397-403. PubMed ID: 20863597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive Drugs in Croatia: What Changes the Drug Usage Patterns?
    Kucan M; Mrsic-Pelcic J; Vitezic D
    Clin Ther; 2018 Jul; 40(7):1159-1169. PubMed ID: 30017168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in osteoporosis medication utilization. A population-based ecological cross-sectional study in the region of Valencia, Spain.
    Sanfélix-Gimeno G; Juliá-Sanchis ML; Librero J; Peiró S; García-Sempere A
    PLoS One; 2018; 13(6):e0199086. PubMed ID: 29927952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in Antiosteoporotic Drug Prescribing and Spending Across Spain. A Population-Based Ecological Cross-Sectional Study.
    Sanfélix-Gimeno G; Librero-López J; Modroño-Riaño G; Peiró S; Rodríguez-Bernal CL
    Front Pharmacol; 2018; 9():342. PubMed ID: 29706889
    [No Abstract]   [Full Text] [Related]  

  • 6. The influences of Taiwan's generic grouping price policy on drug prices and expenditures: evidence from analysing the consumption of the three most-used classes of cardiovascular drugs.
    Chen CL; Chen L; Yang WC
    BMC Public Health; 2008 Apr; 8():118. PubMed ID: 18405385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
    Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI
    Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Direction of pharmacotherapeutic changes used in cardiovascular diseases assessed by examination of two population samples from Warsaw].
    Kuźmińska A; Pìotrowski W; Rywik S; Broda G; Polakowska M
    Pol Arch Med Wewn; 1994 Dec; 92(6):489-98. PubMed ID: 7716052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of utilization of cardiovascular drugs in the Czech Republic and in Wales].
    Górecká K; Vlcek J; Walker R
    Vnitr Lek; 2003 Aug; 49(8):592-7. PubMed ID: 14518081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of COVID-19 on patterns of drug utilization: A case study at national hospital.
    Le-Dang MA; Nguyen-Thi HY; Dinh LP; Ngoc DL; Le NDT; Thu HP; Le DT
    PLoS One; 2024; 19(1):e0297187. PubMed ID: 38241315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are prescribing doctors sensitive to the price that their patients have to pay in the Spanish National Health System?
    González López-Valcárcel B; Librero J; Sanfélix-Gimeno G; Peiró S;
    BMC Health Serv Res; 2011 Dec; 11():333. PubMed ID: 22151628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac medication in the perioperative period.
    Wallner T; Preis C; Mayer N
    Acta Anaesthesiol Scand Suppl; 1997; 111():22-8. PubMed ID: 9420942
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular drug therapy in the elderly.
    Aronow WS; Frishman WH; Cheng-Lai A
    Cardiol Rev; 2007; 15(4):195-215. PubMed ID: 17575484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in attention deficit hyperactivity disorder drugs consumption, Israel, 2005-2012.
    Ponizovsky AM; Marom E; Fitoussi I
    Pharmacoepidemiol Drug Saf; 2014 May; 23(5):534-8. PubMed ID: 24610676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of antihypertensive drugs in Spain (1995-2001)].
    García del Pozo J; Ramos Sevillano E; de Abajo FJ; Mateos Campos R
    Rev Esp Cardiol; 2004 Mar; 57(3):241-9. PubMed ID: 15056428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns.
    Rywik TM; Rywik SL; Korewicki J; Broda G; Sarnecka A; Drewla J
    Int J Cardiol; 2004 Jun; 95(2-3):177-84. PubMed ID: 15193817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of antihypertensive drugs in Spain, 1985-1995].
    Prieto M; de Abajo FJ; Montero D; Martín-Serrano G; Madurga M; Palop R
    Med Clin (Barc); 1998 Feb; 110(7):247-53. PubMed ID: 9562948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consumption trends for specific drugs used to treat dementia in the region of Madrid (Spain) from 2002 to 2012.
    de Hoyos-Alonso MC; Tapias-Merino E; Meseguer Barros CM; Sánchez-Martínez M; Otero A
    Neurologia; 2015 Sep; 30(7):416-24. PubMed ID: 24704249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450-mediated cardiovascular drug interactions.
    Scheen AJ
    Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1065-82. PubMed ID: 21810031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Utilization of cardiovascular drugs in Denmark from 1978 to 1990].
    Johansen UE; Nielsen PE
    Ugeskr Laeger; 1992 Aug; 154(32):2205-8. PubMed ID: 1509607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.